PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Samsara Inc. (IOT)
33.600.80 (-2.33%)
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.87%
Net income growth under 50% of BRZE's 35.47%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-85.57%
Negative yoy D&A while BRZE is 15.09%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
10.75%
SBC growth well above BRZE's 5.30%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-134.02%
Both reduce yoy usage, with BRZE at -143.44%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-327.10%
AR is negative yoy while BRZE is 9.49%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-22.51%
Negative yoy inventory while BRZE is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
179.54%
AP growth well above BRZE's 108.67%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
117.34%
Some yoy usage while BRZE is negative at -325.81%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-103.89%
Both negative yoy, with BRZE at -73.15%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-23.46%
Both yoy CFO lines are negative, with BRZE at -40.13%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
1.38%
Lower CapEx growth vs. BRZE's 58.40%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-31.92%
Both yoy lines negative, with BRZE at -38.22%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
4.07%
Below 50% of BRZE's 22.81%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-101.23%
Both yoy lines negative, with BRZE at -2.89%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1289.41%
Both yoy lines negative, with BRZE at -58.69%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
9.68%
Debt repayment growth of 9.68% while BRZE is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
1894.43%
Stock issuance far above BRZE's 414.83%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.